Efficacy and Underlying Mechanisms of Group Natural Psychotherapy for Anxiety Symptoms

July 25, 2026 updated by: Xiang Yang Zhang, Beijing HuiLongGuan Hospital

Efficacy and Underlying Mechanisms of Group Natural Psychotherapy for Anxiety Symptoms In Chinese University Students

The goal of this clinical trial is to learn if Natural Psychotherapy(NPT) works to treat anxiety symptoms in university students. It will also learn about the efficacy of Natural Psychotherapy in comparison to CBT.

The main questions are: Does online group Natural Psychotherapy lower the participants' anxiety symptoms? Is there any difference between NPT and CBT? Researchers will compare online group Natural Psychotherapy to online group Cognitive Behavioral Therapy(CBT) to see if Natural Psychotherapy works better to lower anxiety symptoms.

Participants will:

Attend online groupNPT or group CBT once a week for 4 weeks; Complete online questionnaires before the intervention, after the first week, after four weeks and after eight weeks.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

55

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Beijing Municipality
      • Beijing, Beijing Municipality, China, 100084

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Voluntarily signed the informed consent form
  • Generalized Anxiety Disorder-7 (GAD-7) total score≥4
  • Chinese
  • Aged 18-30 years, currently enrolled as an undergraduate or postgraduate student.

Exclusion Criteria:

  • Severe depression or high risk of suicide
  • History of substance abuse, drug dependence, or psychotic disorders
  • Severe neurological diseases, severe somatic illnesses, or other conditions unsuitable for physical labor or physical activities
  • History of electroconvulsive therapy (ECT) within the past 6 months, or currently undergoing other pharmacological or systematic psychological treatments.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group Natural Psychotherapy

NPT is a novel approach integrating Japanese Morita therapy and traditional Chinese culture. It proposes three core principles for treating anxiety.

  • Week 1 Focuses on the first principle: endure the pain and do what you should do.
  • Week 2: the second principle is accept the pain and avoid doing what you should not do.
  • Week 3: the third principle is seek pain and do what you fear.
  • Week 4 serves as a consolidation phase where participants synthesize their gains into a personalized coping plan for future relapse prevention.
NPT's principle is fundamentally about fostering a proactive mindset. The participants are encouraged to actively seek out and engage with life's inherent challenges and discomforts as a path to growth. The emphasis is on cultivating courage and initiative as a characterological trait, transforming the individual's relationship with fear itself, rather than solely habituating to specific triggers. This represents a shift from a disorder-specific protocol to a life-oriented philosophy.
Active Comparator: Group Cognitive Behavioral Therapy

A 4-week structured online group CBT intervention will be delivered weekly (90 mins per session) via an online meeting app.

  • Week 1 focuses on psychoeducation regarding anxiety mechanisms and establishing individual CBT loops (Situation-Thought-Emotion-Behavior).
  • Week 2 introduces cognitive restructuring to help participants catch automatic thoughts, check cognitive distortions, and generate balanced thoughts.
  • Week 3 targets behavioral modifications by helping participants recognize avoidance/safety behaviors and design manageable behavioral experiments ("mini-actions").
  • Week 4 serves as a consolidation phase where participants synthesize their gains into a personalized coping plan for future relapse prevention.

Homework compliance (e.g., self-monitoring tables and behavioral logs) is required weekly.

CBT-1 is a 4-week structured online group cognitive behavioral therapy program tailored for college students with subclinical anxiety. The protocol systematically guides participants to deconstruct anxiety into an interconnected loop of situations, automatic thoughts, and behaviors.
Other Names:
  • Natural Psychotherapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Generalized Anxiety Disorder Assessment (GAD-7)
Time Frame: Baseline, After 1 Week, After 4 weeks, After 8 weeks
The GAD-7 is a 7-item, self-reported Likert scale used to assess the severity of participants' anxiety symptoms over the past two weeks. Each item is scored from 0 (not at all) to 3 (nearly every day), yielding a total score ranging from 0 to 21, with higher scores indicating greater anxiety severity. The primary endpoint will evaluate the mean change in GAD-7 scores from baseline (Pre-intervention) to post-intervention (Week 4) to determine the efficacy of the intervention.
Baseline, After 1 Week, After 4 weeks, After 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Beck Depression Inventory(BDI)
Time Frame: Baseline, After 1 week, After 4 weeks, After 8 weeks
The Beck Depression Inventory (BDI) is a 21-item, self-reported Likert scale used to measure the severity of depressive symptoms. Each item is scored on a 4-point scale ranging from 0 to 3. The total score is calculated by summing the scores of all 21 items, yielding a total score range from 0 to 63. Higher total scores indicate more severe depressive symptoms.
Baseline, After 1 week, After 4 weeks, After 8 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Insomnia Severity Index (ISI)
Time Frame: Baseline, After 1 week, After 4 weeks, After 8 weeks
The Insomnia Severity Index (ISI) is a 7-item self-report instrument assessing the nature, severity, and impact of insomnia over the past two weeks. Each item is rated on a 5-point Likert scale from 0 to 4. The total score is obtained by summing all 7 items, ranging from 0 to 28. Higher total scores reflect a higher severity of insomnia symptoms and greater perceived impairment.
Baseline, After 1 week, After 4 weeks, After 8 weeks
State-Trait Anxiety Inventory - State Anxiety (STAI-S)
Time Frame: Baseline, After 4 weeks, After 8 weeks
The State-Trait Anxiety Inventory for State Anxiety (STAI-S) is a 20-item self-report scale evaluating a person's current, transient state of anxiety (how they feel "right now"). Items are scored on a 4-point Likert scale from 1 (not at all) to 4 (very much so). After reverse-scoring appropriate items, the total score ranges from 20 to 80. Higher total scores indicate greater levels of current, situational anxiety.
Baseline, After 4 weeks, After 8 weeks
State-Trait Anxiety Inventory - Trait Anxiety (STAI-T)
Time Frame: Baseline, After 4 weeks, After 8 weeks
The State-Trait Anxiety Inventory for Trait Anxiety (STAI-T) is a 20-item self-report scale assessing relatively stable, long-term personality traits related to anxiety proneness (how they "generally" feel). Items are scored on a 4-point Likert scale from 1 (almost never) to 4 (almost always). After reverse-scoring appropriate items, the total score ranges from 20 to 80. Higher total scores indicate a greater propensity to experience anxiety as a personality trait.
Baseline, After 4 weeks, After 8 weeks
Intolerance of Uncertainty Scale (IUS-12)
Time Frame: Baseline, After 4 weeks, After 8 weeks
The Intolerance of Uncertainty Scale (IUS-12) is a 12-item self-report scale measuring negative emotional, cognitive, and behavioral reactions to uncertainty. Each item is rated on a 5-point Likert scale from 1 (not at all characteristic of me) to 5 (entirely characteristic of me). The total score is computed by summing all items, ranging from 12 to 60. Higher total scores represent a lower tolerance for uncertainty and greater anxiety regarding future events.
Baseline, After 4 weeks, After 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 10, 2026

Primary Completion (Estimated)

July 31, 2026

Study Completion (Estimated)

August 31, 2026

Study Registration Dates

First Submitted

July 7, 2026

First Submitted That Met QC Criteria

July 25, 2026

First Posted (Actual)

July 28, 2026

Study Record Updates

Last Update Posted (Actual)

July 28, 2026

Last Update Submitted That Met QC Criteria

July 25, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ThuPsy-202601

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anxiety Symptoms

Clinical Trials on Natural Psychotherapy

Subscribe